International Clinical Trial: Efficacy and safety of intravenous administration of high-dose selenium for preventing chemotherapy-induced peripheral neuropathy in gynecologic cancer patients

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (KCT0012583) titled 'Efficacy and safety of intravenous administration of high-dose selenium for preventing chemotherapy-induced peripheral neuropathy in gynecologic cancer patients' on Sept. 9.

Study Type: Interventional Study

Study Design: Primary Purpose : Prevention, Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT

Primary Sponsor: Seoul National University Hospital

Condition:

Neoplasms

Intervention: Drug : Participants will be assigned, according to the randomization schedule, to either the investigational group (high-dose selenium group) or the control group ...